The deal is Merck’s largest since 2015, when it spent $17bn on acquiring Sigma-Aldrich, also a life sciences specialist.

A groundbreaking advancement in technology has emerged: scientists have developed a bio-computer using human cells. This ...

AI drug discovery cleared its first Phase IIa clinical test in 2025, as BIO 2026 confirmed the shift from speculation to ...

A German company that provides products and services that accelerate drug development and manufacturing is set to acquire the ...

Merck KGaA, Darmstadt, Germany, has agreed to acquire Bio-Techne for approximately $11.3 billion, the companies said today, in a deal designed to position the buyer as more of a leader across the life ...

Wheeler Bio, an Oklahoma-based Contract Development and Manufacturing Organization (CDMO) specializing in antibody-based therapeutics, today announced the launch of its redesigned website, showcasing ...

In collaboration with InvestHK and HKTDC, HKSTP led a delegation of 41 park companies, institutes and spin-offs from five renowned local universities to showcase the Hong Kong’s life and health ...

Dr. Hubert Scholze, Chief Business Officer, Rezon Bio. As a member of Rezon Bio’s Executive Leadership Team, Dr. Hubert ...

Merck KGaA, Darmstadt, Germany, a leading science and technology company, and Bio-Techne Corporation, a Minneapolis-based ...

Financing follows Torres's CrossBridge Bio acquisition by Eli Lilly and supports translation of ARTAN Bio's programmable approach to mutation-driven aging biology. ST. PETERSBURG, ...

Alabama A&M University received a $600,000 USDA grant to integrate data science into agriculture and environmental sciences.

German drugmaker Merck ​KGaA said on Thursday it will acquire U.S. biotech firm Bio-Techne for $11.3 billion, its largest ...